- Home
- CRBU vs AMPY Comparison
CRBU vs AMPY Comparison
Compare CRBU & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRBU | AMPY |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.4M | 215.9M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CRBU | AMPY |
|---|---|---|
| Price | $1.92 | $4.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.75 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 680.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.64 | ★ 232.26 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $208,637,000.00 |
| Revenue This Year | $1.63 | N/A |
| Revenue Next Year | $10.93 | $23.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.04 | $3.11 |
| 52 Week High | $3.53 | $6.79 |
Technical Indicators
Market Signals| Indicator | CRBU | AMPY |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 28.40 |
| Support Level | $1.75 | $4.13 |
| Resistance Level | $2.09 | $4.92 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 7.98 | 3.02 |
Price Performance
Historical ComparisonAbout CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.